CUSIP: 29363K105
Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
11,788,541
-
Share change
-
-96,196
-
Total reported value
-
$198,751,700
-
Price per share
-
$16.86
-
Number of holders
-
51
-
Value change
-
-$2,012,370
-
Number of buys
-
25
-
Number of sells
-
18
Quarterly Holders Quick Answers
What is CUSIP 29363K105?
CUSIP 29363K105 identifies ENTL - ENTELLUS MED INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2016
-
Previous quarter:
Q3 2015
Recent filing periods for CUSIP 29363K105:
Institutional Holders of ENTELLUS MED INC - COM (ENTL) as of Q4 2015
As of 31 Dec 2015,
ENTELLUS MED INC - COM (ENTL) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,788,541 shares.
The largest 10 holders included
Essex Woodlands Health Ventures, Inc., SV Life Sciences Advisers, LLC, FMR LLC, RS INVESTMENT MANAGEMENT CO LLC, WELLS FARGO & COMPANY/MN, First Light Asset Management, LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., PRICE T ROWE ASSOCIATES INC /MD/, ADAGE CAPITAL PARTNERS GP LLC, and VANGUARD GROUP INC.
This page lists
51
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.